January 09, 2012
Press Release No. 1
Clarification by Piramal Life Sciences
Limited
Significant price movement has been observed in
Piramal Life Sciences Limited.
The Exchange, in order to ensure that investors have
latest relevant information about the company and to inform the market place so
that the interest of the investors is safeguarded, had written to the company.
Piramal Life Sciences Limited has vide its letter inter-alia stated, "We
are not aware of any information/announcement (including impending
announcement) which in our opinion may have a bearing on the price/volume
behaviour in the scrip."
Press Release No. 2
NSE completes its 2965th
Normal Settlement
The Exchange has
successfully completed its 2965th Normal
Settlement (Rolling T+2 following SEBI directive) since inception i.e.,
Settlement Number N – 2012004 on Jan 09, 2012. The settlement statistics are as
follows:
|
Particulars |
|
|
|
N-2012004 |
|
Total traded quantity (lakhs) |
5209.80 |
|
Total traded value (Rs. In Crores) |
9239.59 |
|
Total value of the settlement (Securities) (Rs. In Crores) |
2289.65 |
|
Total value of the settlement (Funds) (Rs. In Crores) |
861.89 |
|
Shortages for the settlement |
0.10% |
|
% of Delivery ( No. of shares
deliverable / No. of shares traded ) |
25.07% |
Retail Debt
Market has completed its 2238th settlement, details of which are as
follows:
|
Settlement
No. |
Traded
Value |
Settlement
Value |
|
|
|
|
Securities |
Funds |
|
D- 2012004 |
NIL |
NIL |
NIL |